The offer is likely to be rejected by above 39% of shareholders unless price is significantly increased.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
Carasent ASA (“Carasent”) refers to the stock exchange release from EG A/S (“EG”) 29 April 2024 regarding EG’s intention to make a cash tender offer for all shares in Carasent at NOK 20 per share and Carasent’s immediate comments in a subsequent stock exchange release.
In response to Carasent’s communication that it may seek to entertain discussions and permit due diligence with interested parties, shareholders holding above 39% of the shares have informed Carasent that they are not minded to accept any offer which is not significantly above the level proposed by EG. This includes the 16.6% stake of Vitruvian Partners.
Due to EG’s announced intention to make an offer, Carasent presently remains inclined to continue to discuss opportunities for a transaction with EG and others. It is not known whether any such discussions will result in any proposed transaction or the price and other terms of such proposed transaction, be it in the form of a voluntary offer for Carasent’s shares or in any other form.
Carasent does not intend to make any public announcement in respect of any such discussions unless and until such discussions might have resulted in any definitive agreement in respect of any such proposed transaction.
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 the Norwegian Securities Trading Act.
